Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Gossamer Bio Inc (GOSS)

Gossamer Bio Inc (GOSS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Gossamer Bio Inc 3013 Science Park Road SAN DIEGO CA 92121 USA

www.gossamerbio.com P: 858-684-1300

Description:

Gossamer Bio Inc. is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing and commercializing therapeutics in the areas of immunology, inflammation and oncology. The company's product pipeline includes GB001, GB002, GB004, GB1275, Autoimmune program and Oncology program which are in clinical stage. Gossamer Bio Inc. is based in San Diego, California.

Key Statistics

Overview:

Market Capitalization, $K 159,780
Enterprise Value, $K 140,090
Shares Outstanding, K 225,582
Annual Sales, $ 0 K
Annual Net Income, $ -179,820 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -48,150 K
EBIT, $ -183,760 K
EBITDA, $ -187,500 K
60-Month Beta 1.71
% of Insider Shareholders 9.50%
% of Institutional Shareholders 81.23%
Float, K 204,152
% Float 90.50%
Short Volume Ratio 0.35

Growth:

1-Year Return -40.18%
3-Year Return -92.25%
5-Year Return -96.17%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 94.78%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.21 on 03/05/24
Latest Earnings Date 05/14/24
Earnings Per Share ttm -1.39
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year 64.41%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

GOSS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -944.79%
Return-on-Assets % -67.76%
Profit Margin % 0.00%
Debt/Equity 0.20
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 2.67
Book Value/Share 0.28
Interest Coverage -12.31
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar